MedPath

Analgesic Effect of Paracetamol in Patients With Femur Fracture: is Intravenous Better Than Oral?

Completed
Conditions
Femur Fracture
Interventions
Registration Number
NCT05025228
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The purpose of this study is to monitor severe pain for femur fracture after treatment with paracetamol IV or OR.

Detailed Description

The investigators enrolled 170 consecutive patients with femur fracture and severe pain. The patients received an initial analgesic treatment with paracetamol orally (OR) or intravenously (IV). The primary outcome was the reduction of pain of 1 point at visual analogue scale for pain (VAS) after the 1 st hour of treatment (T1). Secondary endpoints included the reduction of pain of at least 2 points on the VAS scale at the 4 th hour (T4), the need of rescue therapy and the number of adverse events.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • Age ≥ 18 years
  • Patients admitted to the ED of Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome
  • Femur Fracture
  • Patients who signed the informed consent
  • Able to take analgesic therapy both orally (OR) and intravenously (IV)
  • Able to define pain by VAS
Exclusion Criteria
  • Age <18 years
  • Allergy to paracetamol
  • Unable to take analgesic therapy both orally (OR) and intravenously (IV)
  • Unable to define pain by VAS

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Paracetamol IVParacetamolPatients with femur fracture that received an initial analgesic treatment with paracetamol intravenously (IV).
Paracetamol ORParacetamolPatients with femur fracture that received an initial analgesic treatment with paracetamol orally (OR).
Primary Outcome Measures
NameTimeMethod
Pain change of 1 point at visual analogue scale for pain (VAS) after the 1 st hour of treatment (T1).Baseline and 1 hour

The Visual Analogue Scale for Pain (VAS) is a validated self-reported instrument that identifies pain from 0 to 10 (with 0 = no pain and 10 = maximum pain intensity)

Secondary Outcome Measures
NameTimeMethod
Pain change of at least 2 points on the VAS scale at the 4 th hour (T4)Baseline and 4 hours

identifies pain from 0 to 10 (with 0 = no pain and 10 = maximum pain intensity)

Trial Locations

Locations (1)

Fondazione Policlinico Universitario Agostino Gemelli, IRCCS

đŸ‡®đŸ‡¹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath